Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — August 2023

Genmab — August 2023

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #79

    Passer fint med at venetoclax er med i Epcore cll https://classic.clinicaltrials.gov/ct2/show/NCT04623541?term=Epcore+cll+1&draw=2&rank=1

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #80

      Både lenalidomid og veneto er gode kombipartnere til sc epco, da de begge er i tabletform.

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #81

        Godmorgen 🙂

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Stroka
          wrote on sidst redigeret af
          #82

          God morgen 🙂

          1 Reply Last reply
          0
          • B Offline
            B Offline
            bibob
            wrote on sidst redigeret af
            #83

            God morgen. 🙂

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #84

              venetoclax is from AbbVie, isn't it. There is also this epcoritamab + venetoclax trial https://classic.clinicaltrials.gov/ct2/show/NCT05791409

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #85

                Yes it is AbbVie. Venclyxto.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #86

                  Hm, ser vi bort fra Bava er det medicinal på taberlisten i dag.

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #87

                    Groundhog day

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #88

                      "Den fede dame" har ikke sunget endnu Bulder;-)

                      1 Reply Last reply
                      0
                      • R Offline
                        R Offline
                        Riis7
                        wrote on sidst redigeret af
                        #89

                        Man kan ikke bruge den us kurs til meget,
                        åbner altid under i dk:-)

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #90

                          Næh, synes bare at jeg øjnede et halmstrå i de grønne farma-aktier i us i går. Og at det så skulle være overstået. Men futterne dykker igen. Trist.

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Riis7
                            wrote on sidst redigeret af
                            #91

                            vejret og aktierne er triste i dag:-)

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #92

                              Spændende om vi får lidt mere at vide om innova tecvayli 301 i dag, siden de nu venter topline resultater allerede i år. Måske vil en godkendelse kunne nås til næste år, og så har vi Tivdak i 2. linje.

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #93

                                Ipad rettede TV til tecvayli

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #94

                                  yes, we would really need to get further up the line to see additional revenue, and hopefully some data on other tumors

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #95

                                    further not that much to expect this evening i guess... even though we should expect genmab at some point to mention something about GEN1047 DuoBody-CD3xB7H4

                                    and GEN3009 DuoHexabody-CD37
                                    ; they will have to make a decision at some point to continue or not

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #96

                                      And also a confimation that we can expect data from 1042 and 1046 this year.

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #97

                                        Right now an announcement that jnj has chosen to opt in on hex38 would be very useful. 😉

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #98

                                          Also a BL.A. in immunology with one of Genmabs own antibodies maybe

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper